Skip to content

Public FDA record

Z-3026-2020: ZEUS ELISA Parvovirus B19 IgM Test System, UDI 00845533001755 - Product Usage: intended for the qualitati

Recall record Z-3026-2020 for Zeus Scientific, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-3026-2020
Company in FDA record
Zeus Scientific, Inc.
FDA record creation date
Sep 29, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

FDA inspection identified that due to increased positivity (false positives) on the Parvovirus B19 ELISA Test System, the firm assigned a new Correction Factor and new lot number to the remainder of the affected lot, and distributed the reworked product to the customer.

Source facts

Action
Pending. The firm has not initiated customer notification for this issue.
Initiated
2019-08-12
Root cause
Unknown/Undetermined by firm
Terminated
2022-05-20
Distribution
Worldwide distribution - US Nationwide distribution including in the states of CA, CT, IN, NJ, TX and the country of Canada.
Recall number
Z-3026-2020
Recall status
Terminated
CDRH record ID
183485
FDA record created
2020-09-29
Recall event number
86364

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗